HMGA2 and breast carcinoma: Silencing of HMGA2 in the invasive breast cancer cell model MDA-MB-231 affected, in addition to E-cadherin, the expression of invasive genes, such as MMP2 and TNC, and reduced the rate of motility and infiltration of cells through matrigel (Supplementary Figure S3).